Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brenton

Showing results (141-150 of 229) with videos related to

Pageof 23
Sort By:
Plos One|July 9, 2020
Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 geneLorenza Mittempergher, Anna M Piskorz, Astrid J Bosma, et al.
Scientific Reports|July 26, 2019
Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancerSurrin S Deen, Andrew N Priest, Mary A McLean, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Exome sequencing identifies <i>HELB</i> as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancerEd M Dicks, Jonthan P Tyrer, Suzana Ezquina, et al.
Human Pathology|May 4, 2020
Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinomaBasile Tessier-Cloutier, Dawn R Cochrane, Anthony N Karnezis, et al.
Frontiers in Oncology|July 5, 2022
Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian CarcinomaLeonardo Rundo, Lucian Beer, Lorena Escudero Sanchez, et al.
British Journal of Cancer|March 30, 2021
Promises and challenges of adoptive T-cell therapies for solid tumoursMatteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
Cells|February 21, 2020
<i>PIK3R1</i><sup>W624R</sup> Is an Actionable Mutation in High Grade Serous Ovarian CarcinomaConcetta D'Ambrosio, Jessica Erriquez, Maddalena Arigoni, et al.
BJR Open|September 15, 2022
Magnetization transfer imaging of ovarian cancer: initial experiences of correlation with tissue cellularity and changes following neoadjuvant chemotherapySurrin S Deen, Mary A McLean, Andrew B Gill, et al.
Nature Communications|May 6, 2020
Genomic landscape of platinum resistant and sensitive testicular cancersChey Loveday, Kevin Litchfield, Paula Z Proszek, et al.
Nature Communications|October 16, 2023
Molecular landscape and functional characterization of centrosome amplification in ovarian cancerCarolin M Sauer, James A Hall, Dominique-Laurent Couturier, et al.
Pageof 23

Showing results (141-150 of 229) with videos related to

Sort By:
Pageof 23
Plos One|July 9, 2020
Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 geneLorenza Mittempergher, Anna M Piskorz, Astrid J Bosma, et al.
Scientific Reports|July 26, 2019
Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancerSurrin S Deen, Andrew N Priest, Mary A McLean, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Exome sequencing identifies <i>HELB</i> as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancerEd M Dicks, Jonthan P Tyrer, Suzana Ezquina, et al.
Human Pathology|May 4, 2020
Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinomaBasile Tessier-Cloutier, Dawn R Cochrane, Anthony N Karnezis, et al.
Frontiers in Oncology|July 5, 2022
Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian CarcinomaLeonardo Rundo, Lucian Beer, Lorena Escudero Sanchez, et al.
British Journal of Cancer|March 30, 2021
Promises and challenges of adoptive T-cell therapies for solid tumoursMatteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
Cells|February 21, 2020
<i>PIK3R1</i><sup>W624R</sup> Is an Actionable Mutation in High Grade Serous Ovarian CarcinomaConcetta D'Ambrosio, Jessica Erriquez, Maddalena Arigoni, et al.
BJR Open|September 15, 2022
Magnetization transfer imaging of ovarian cancer: initial experiences of correlation with tissue cellularity and changes following neoadjuvant chemotherapySurrin S Deen, Mary A McLean, Andrew B Gill, et al.
Nature Communications|May 6, 2020
Genomic landscape of platinum resistant and sensitive testicular cancersChey Loveday, Kevin Litchfield, Paula Z Proszek, et al.
Nature Communications|October 16, 2023
Molecular landscape and functional characterization of centrosome amplification in ovarian cancerCarolin M Sauer, James A Hall, Dominique-Laurent Couturier, et al.
Pageof 23